BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
Europe - FRA:BRYN - US0846707026 - Common Stock
425.6 EUR
+4.3 (+1.02%)
Taking everything into account, BRYN scores 5 out of 10 in our fundamental rating. BRYN was compared to 50 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on BRYN. These ratings would make BRYN suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year BRYN was profitable.
BRYN had a positive operating cash flow in the past year.
BRYN had positive earnings in 4 of the past 5 years.
BRYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 5.41%, BRYN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
BRYN has a Return On Equity of 9.42%. This is in the better half of the industry: BRYN outperforms 66.00% of its industry peers.
The Return On Invested Capital of BRYN (4.37%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BRYN is below the industry average of 8.73%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROIC | 4.37% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
BRYN has a Profit Margin of 17.00%. This is in the better half of the industry: BRYN outperforms 74.00% of its industry peers.
BRYN's Profit Margin has declined in the last couple of years.
BRYN has a Operating Margin of 15.70%. This is in the better half of the industry: BRYN outperforms 66.00% of its industry peers.
In the last couple of years the Operating Margin of BRYN has grown nicely.
BRYN's Gross Margin of 16.97% is on the low side compared to the rest of the industry. BRYN is outperformed by 60.00% of its industry peers.
In the last couple of years the Gross Margin of BRYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
Compared to 1 year ago, BRYN has less shares outstanding
The number of shares outstanding for BRYN has been reduced compared to 5 years ago.
BRYN has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.43, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.43, BRYN perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
BRYN has a debt to FCF ratio of 15.44. This is a negative value and a sign of low solvency as BRYN would need 15.44 years to pay back of all of its debts.
BRYN has a Debt to FCF ratio of 15.44. This is in the lower half of the industry: BRYN underperforms 62.00% of its industry peers.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.19, BRYN is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Altman-Z | 1.43 |
ROIC/WACC1.36
WACC3.22%
2.3 Liquidity
BRYN has a Current Ratio of 1.95. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.95, BRYN is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
A Quick Ratio of 1.68 indicates that BRYN should not have too much problems paying its short term obligations.
BRYN's Quick ratio of 1.68 is fine compared to the rest of the industry. BRYN outperforms 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.24%, which is quite good.
The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
Looking at the last year, BRYN shows a small growth in Revenue. The Revenue has grown by 0.01% in the last year.
BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
3.2 Future
The Earnings Per Share is expected to grow by 2.26% on average over the next years.
Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 4.89% on average per year.
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
BRYN is valuated cheaply when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRYN to the average of the S&P500 Index (23.23), we can say BRYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.02 |
4.2 Price Multiples
BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 94.00% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.09 | ||
| EV/EBITDA | 0.34 |
4.3 Compensation for Growth
The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.07%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (10/21/2025, 7:00:00 PM)
425.6
+4.3 (+1.02%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners34.67%
Inst Owner ChangeN/A
Ins Owners38.36%
Ins Owner ChangeN/A
Market Cap612.86M
Analysts80
Price Target454.8 (6.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-9.78%
Max EPS beat(2)0.19%
EPS beat(4)2
Avg EPS beat(4)5.7%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.53%
EPS beat(12)8
Avg EPS beat(12)6.49%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)0
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-2.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)3
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1.25%
PT rev (1m)0.23%
PT rev (3m)-1.25%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)0.37%
EPS NY rev (1m)0%
EPS NY rev (3m)2.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.02 | ||
| P/S | 0 | ||
| P/FCF | 0.09 | ||
| P/OCF | 0.03 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 0.34 |
EPS(TTM)27102.59
EY6368.09%
EPS(NY)28346.94
Fwd EY6660.47%
FCF(TTM)4900.73
FCFY1151.49%
OCF(TTM)16333
OCFY3837.64%
SpS220548.52
BVpS398010.51
TBVpS326855
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROCE | 5.42% | ||
| ROIC | 4.37% | ||
| ROICexc | 4.82% | ||
| ROICexgc | 5.84% | ||
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% | ||
| FCFM | 2.22% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Debt/EBITDA | 1.78 | ||
| Cap/Depr | 146.66% | ||
| Cap/Sales | 5.18% | ||
| Interest Coverage | 11.47 | ||
| Cash Conversion | 38.5% | ||
| Profit Quality | 13.07% | ||
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 1.43 |
F-Score4
WACC3.22%
ROIC/WACC1.36
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
EBIT growth 1Y6.42%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.47%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-36.42%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%